US · Healthcare

Syros Pharmaceuticals Inc (SYRS)

Biotechnology

Syros Pharmaceuticals Inc (SYRS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SYRS

P/E ratio

25.00

Syros Pharmaceuticals Inc (SYRS) — FAQ

What is SYRS's P/E ratio?

The price-to-earnings (P/E) ratio for Syros Pharmaceuticals Inc (SYRS) is 25.00 (data as of 2026-05-23).

Does Syros Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Syros Pharmaceuticals Inc (SYRS). Check the MyAverix Finance app for the latest dividend data.

What sector is Syros Pharmaceuticals Inc in?

Syros Pharmaceuticals Inc (SYRS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SYRS listed on?

SYRS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)